INS and Hyperglycemia: mTOR-I administered to an animal model of nutrition-dependent type 2 diabetes (diabetic Psammomys obesus) worsened the metabolic state of the diabetic animals: augmented insulin resistance, β-cell dysfunction, and death, thereby preventing β-cell adaptation to hyperglycemia (41).